We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

81 hedge funds and large institutions have $144M invested in Corbus Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 17

0.09% more ownership

Funds ownership: 1.28% → 1.37% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less capital invested

Capital invested by funds: $150M → $144M (-$6.12M)

8% less funds holding

Funds holding: 88 → 81 (-7)

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

76% less call options, than puts

Call options by funds: $418K | Put options by funds: $1.71M

Holders
81
Holders Change
-7
Holders Change %
-7.95%
% of All Funds
1.86%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
36
Reduced
17
Closed
15
Calls
$418K
Puts
$1.71M
Net Calls
-$1.29M
Net Calls Change
-$161K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.1M
2
EMG
ETF Managers Group
New Jersey
+$16.7M
3
State Street
State Street
Massachusetts
+$706K
4
Morgan Stanley
Morgan Stanley
New York
+$453K
5
VEA
Virtus ETF Advisers
New York
+$412K

Top Sellers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
-$4.26M
2
Millennium Management
Millennium Management
New York
-$4M
3
AG
Artal Group
Luxembourg
-$2.84M
4
SFM
Sphera Funds Management
Israel
-$2.66M
5
PA
Perceptive Advisors
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$26.8M +$17.1M +76,323 +109%
KCM
2
Knoll Capital Management
Florida
$23.5M – – –
BlackRock
3
BlackRock
New York
$22.3M +$402K +1,790 +1%
EMG
4
ETF Managers Group
New Jersey
$14.5M +$16.7M +74,308 +979%
Vanguard Group
5
Vanguard Group
Pennsylvania
$13.2M +$144K +639 +0.9%
IA
6
IFP Advisors
Florida
$7.11M – – –
State Street
7
State Street
Massachusetts
$4.86M +$706K +3,143 +13%
BBA
8
Baker Bros. Advisors
New York
$4.03M – – –
Morgan Stanley
9
Morgan Stanley
New York
$3.78M +$453K +2,016 +11%
Northern Trust
10
Northern Trust
Illinois
$3.25M +$58.4K +260 +1%
RJFSA
11
Raymond James Financial Services Advisors
Florida
$2.59M -$79.1K -352 -2%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$2.52M +$33.2K +148 +1%
Jennison Associates
13
Jennison Associates
New York
$1.26M -$136K -606 -8%
Creative Planning
14
Creative Planning
Kansas
$1.21M +$147K +653 +11%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$1.16M +$1.35K +6 +0.1%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$1.03M +$64.5K +287 +5%
Allianz Asset Management
17
Allianz Asset Management
Germany
$840K +$140K +625 +16%
TCIM
18
TIAA CREF Investment Management
New York
$758K +$64.2K +286 +7%
VEA
19
Virtus ETF Advisers
New York
$625K +$412K +1,835 +116%
Charles Schwab
20
Charles Schwab
California
$591K – – –
TA
21
Teachers Advisors
New York
$574K +$73.2K +326 +12%
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$552K +$170K +757 +33%
Wells Fargo
23
Wells Fargo
California
$493K +$17.7K +79 +3%
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$456K -$12.1K -54 -2%
WC
25
Woodstock Corp
Massachusetts
$439K – – –
1
2 3 4

CRBP Hedge Fund Activity: Q1 2018 in Review

81 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q1 2018, worth a combined $144M — down 4.1% from $150M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of CRBP and 11 opened new positions — a net loss of 4 holders — while 17 trimmed existing stakes and 36 added.

The largest buyer was Fidelity Investments, adding an estimated $17.1M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.26M sold.

  • 81 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q1 2018, down from 88 in Q4 2017.
  • Funds reported $144M of Corbus Pharmaceuticals stock for Q1 2018, down 4.1% quarter-over-quarter.
  • 11 funds opened new Corbus Pharmaceuticals positions in Q1 2018 and 15 closed out, a net change of -4 holders.
  • The largest Corbus Pharmaceuticals buyer in Q1 2018 was Fidelity Investments, an estimated $17.1M added.
  • The largest Corbus Pharmaceuticals seller in Q1 2018 was Great Point Partners, an estimated $4.26M sold.

Based on aggregated 13F filings for Q1 2018.